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ABSTRACT 
Biomaterials have been used to repair the human body for millennia, but it is only 
since the 1970s that man made composites have been used. Hydroxyapatite reinforced 
polyethylene is the first of the “Second Generation” biomaterials that have been 
developed to be bioactive. The mechanical properties have been characterised, using 
quasistatic, fatigue, creep and fracture toughness testing and these studies have 
allowed optimisation of the production method. The in vitro and in vivo biological 
properties have been investigated with a range of filler content and have shown that 
the presence of sufficient bioactive fillers leads to a bioactive composite. Finally the 
material has been applied clinically initially in the orbital floor and then in the middle 
ear. From this initial combination of hydroxyapatite in polyethylene other bioactive 
ceramic polymer composites have been developed.  
 
Keywords:  Bioactive composites, hydroxyapatite, polymers, bone replacement, 
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INTRODUCTION 
Biomaterials have been used since 
prehistoric times, such as the use of 
nacre (mother of pearl) by the Mayans 
to integrate dental implants into bone 
(Westbroek & Marin, 1998). While in 
the 19th Century silver coated steel 
fracture fixation plates used to repair 
patella fractures in the USA (Parkhill, 
1897). However, in the 1970s the early 
hip and knee replacements started to 
fail in significant numbers. Prior to this 
time, joint replacements had been 
confined to an elderly and very low 
activity patient cohort and the implants 
were able to outlive their recipients. 
The implants were loosening with 
large areas of osteolytic (bone) 
resorption, so much so that at revision 
surgery the implants could be removed 
with minimal effort. The rationale for 
these failures was considered in detail 
and the concepts of  “cement disease” 
and “stress shielding” were developed 
(Engh et aI., 1987; Harrigan et al., 
1992). 
“Cement disease” was considered a 
biological response to the long term 
application of bone cement (Charnley, 
1975; Jones and Hungerford 1987). 
Fatigue of bone cement leads to the 
production of cement particles and the 
release of the zirconia or barium 
sulphate particles used as radiographic 
opacifiers. These opacifier particles 
then become entrapped in the 
articulating surfaces of the prosthesis 
and accelerate the production of wear 
particles of the polyethylene and metal 
components of the joint replacement. 
Cement, cement opacfier, polyethylene 
and metal particles have all been found 
in the osteolytic lesions surrounding 
loose joint replacements. A dose 
dependant response has been seen with 
over 1010 polymer particles per gram 
of wet tissue being found in osteolytic 
lesions (Kadoya et al., 1997, 
Kobayashi et al., 1997). Other studies 
have shown that these wear particles 
can cause macrophages to initiate bone 
resorption (Quinn et al., 1992; 
Sabokbar, et al., 1996).  
Stress shielding is due to the mis-
match between the stiffness of bone 
which has a Young’s modulus of 7-
25GPa (for example, Bonfield & 
Grynpas, 1977; Currey, 1998) and 
210GPa for stainless steel implant 
stems. Various methods of solving this 
problem were considered including 
changing the size and shape of the 
stem to reduce the differences in the 
structural stiffness of the implant and 
the surrounding bone and changing the 
implant material from steel to 
commercially pure titanium or Ti-
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6%Al-4%V alloy (Sarmiento et al., 
1979). 
At this time Katz and Lakes (Lakes et 
al 1977; Lakes & Katz 1977a&b), 
Currey (1969 & 1999) and Bonfield 
(Bonfield & Li, 1966 & 1967; 
Bonfield & Grynpas 1977) were all 
investigating the mechanical properties 
of bone, its structure and anisotropy. 
Katz presented the idea that bone itself 
is “a composite of a composite of a 
composite” working from the 
macroscale to the nanoscale (Katz et 
al., 2007). Thus Bonfield and 
colleagues at Queen Mary College, 
University of London developed the 
concept of manufacturing an analogue 
of bone itself of polyethylene 
reinforced with hydroxyapatite 
(Bonfield et al., 1980, 1981; Bonfield, 
1988). All the biocompatible metals 
and bioceramics available at that time 
are stiffer than bone, while the 
polymers are more flexible, both cases 
leading to stress concentrations at the 
implant bone interface. Bonfield and 
colleagues also realised that if they 
used polyethylene (PE) and 
hydroxyapatite (HA) the material 
could potentially be bioactive due to 
the presence of the HA and that 
approval for clinical use should be 
simplified as the individual materials 
were already approved for clinical 
applications. The composite with 
40vol% HA was given the trade name 
HAPEX™, thus in this paper HA/PE is 
used to describe materials with 
different filler contents and HAPEX™ 
the 40vol% HA composite used 
clinically.  
Bonfield (1988) described bioinert 
materials such as stainless steel and PE 
as the “First Generation” biomaterials 
and the materials aiming to interact 
beneficially with the body, such as 
HAPEX™and Bioglass® as “Second 
Generation” biomaterials while Hench 
and Polak (2002) have described 
resorbable and bioactive materials as 
“Third Generation” biomaterials, as 
they “help the body heal itself”.  
 
MATERIAL PRODUCTION  
In composites the mechanical 
properties are strongly controlled by 
the production method. In 
collaboration with Brunel University 
twin screw compounding extrusion 
was used to add HA into high density 
PE (HDPE). Through all the studies 
HDPE was used as it can be processed 
by compounding and extrusion unlike 
ultra high molecular weight PE, which 
can only be compression moulded 
from powder. The initial studies used 
calcined bovine bone ash with a mean 
particle size of 10µm (Bonfield et al., 
1980, 1981). The bone ash was 
replaced with synthetically produced 
hydroxyapatite with a smaller mean 
particle size of 4µm, which did, to 
some extent, improve the mechanical 
properties, but also allowed more 
reproducible and controllable starting 
HAs to be used. Twin screw 
compounding extrusion generates high 
shear forces ensuring that upto 50vol% 
HA could be compounded into the 
polyethylene. Tensile testing showed 
that the increase in HA content lead to 
increases in the Young’s modulus from 
1.3±0.2GPa for the unfilled 
polyethylene through to 7.7±1.3GPa 
for 50vol%, however at 45vol% the 
tensile strength started to drop and the 
failure mode changed from ductile to 
brittle, as instead of the material 
consisting of HA particles totally 
surrounded by PE which acted as 
matrix, HA to HA particle contact 
occurred (Table 1). Thus from this 
time the all studies were confined to no 
higher than 40vol% HA. In 
comparison the volume content of 
bone mineral of human bone is 
between 45 and 50vol% and the bone 
mineral particles are nanometre size 
with various estimates for particle size 
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including 5×5×20 and 5×10×40 nm 
(Currey 1998). 
 
 
 
Table 1 Mechanical properties and bioactivity of hydroxyapatite reinforced 
polyethylene composites (from Bonfield, 1988) 
Hydroxyapatite 
volume 
fraction 
Young’s 
Modulus 
/GPa 
Strain to 
Fracture 
/% 
Fracture 
mode 
Bioactivity (bone 
apposition 
around implant) 
0 1.3 ± 0.2 >90 Ductile × 
10 1.4 ± 0.2 79 ± 10 Ductile ?? 
20 2.0 ± 0.1 50 ± 4 Ductile ?? 
25 2.5 ± 0.2 43 ± 3 Ductile ?? 
30 3.0 ± 0.2 34 ± 5 Ductile ?? 
35 3.7 ± 0.4 32 ± 8 Ductile ?? 
40 4.4 ± 0.7 29 ± 5 Ductile √ 
45 5.9 ± 0.5 7 ± 3 Brittlea ?? 
50 7.7 ± 1.3 3 ± 1 Brittleb √ 
a  KIC = 2.9 ± 0.3 MN m-3/2 
b  KIC = 2.4 ± 0.2 MN m-3/2 
 
Various studies have investigated the 
effect of altering particle size and 
particle morphology. Wang et al. 
(1994 & 1998b) compared two grades 
of spray dried HA: one with a mean 
particle size of 4.14µm and a specific 
surface area of 8.27m2g-1 and the other 
with a mean particle size of 7.32µm 
and a specific surface area of 7.61m2g-
1, but both produced by spray drying 
leading to each particle being an 
agglomerate of nanocrystallites. Minor 
differences in the tensile strength were 
seen for the different filler particles 
and the filler contents investigated, 
however the tensile and torsional 
stiffnesses were higher with the 
smaller filler particles. Joseph et al. 
(2002a) investigated the effect of HA 
particle shape and used a spray dried 
and a sintered grade of HA powder 
with similar particle size distributions 
and mean particle sizes of 4.02 and 
3.58µm respectively, but a factor of 
over 10 difference in the specific 
surface areas. They compound 
extruded the composite and then 
characterised the rheological 
properties. The HA/PE manufactured 
with the spray dried HA had 
substantially higher viscosity than that 
manufactured using the sintered HA 
(Figure 1). They suggested that the 
difference was produced by the 
amount of PE involved in coating the 
HA particles and thus how much was 
free to act as matrix between the 
coated particles (Figure 2). To improve 
the impact properties of the composites 
Zhang and Tanner (2008) produced 
composites using sintered particles of 
HA for comparison to the spray dried 
HA filled composites. These two HAs 
were again chosen to have similar 
particle size and particle size 
distribution with mean values of 
3.80µm and 4.46µm, but different 
specific surface areas of 13.536 and 
0.965m2g-1 for the spray dried and 
sintered HA, respectively. Composites 
with 20, 30 and 40vol% filler were 
manufactured and subjected to impact 
testing, using an instrumented falling 
weight impact tester. For all volume 
fractions both the initiation and 
propagation energies were higher with 
the sintered HA with the lower surface 
area. SEM of the fracture surfaces 
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showed that the smoother particles 
allowed more polyethylene drawing 
during the fracture process (Figure 3) 
in agreement with the concept of 
Joseph et al. (2002a) of the effect of 
specific surface area.  
 
 
Figure 1 Apparent shear viscosity of 48,650 Mw PE reinforced with 40vol% spray 
dried HA (P205) and sintered HA particles (P215) at temperatures between 200 and 
250˚C. (From Joseph et al., 2002a). 
 
 
Figure 2 Schematic showing the different amounts of matrix used to coat high specific 
surface area spray dried HA (P205) versus sintered low specific surface HA (P215S) 
(From Joseph et al., 2002a) 
 
Spray dried HA Sintered HA 
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a)  b)  
Figure 3 Impact facture surfaces of 30vol% a) spray dried HA and b) sintered HA in 
polyethylene, showing the longer draw fibrils with the lower surface area filler 
particles. (From Zhang & Tanner, 2008) 
 
The effect of HDPE molecular weight 
was investigated by both Joseph et al. 
(2002b) and Zhang and Tanner (2003). 
Joseph et al. (2002b) were interested in 
producing an injection moulding grade 
of HA/PE, thus they used three grades 
of HDPE with melt flow indices 
between 7.6 and 26 g (10min)-1, that is 
molecular weights between 72,350 and 
48,650 respectively and filled these 
PEs with 0, 20 and 40vol% spray dried 
HA. The effect of the increasing filler 
content or the molecular weight was to 
increase the shear stress at any shear 
rate during injection moulding. Zhang 
and Tanner (2003) used two different 
HDPEs with melt flow indices of 6 and 
26 g (10min)-1 that is molecular 
weights of 249,233 and 48,650 
respectively. Under drop weight 
impact testing the effect of molecular 
weight was substantial with the energy 
absorbed being 5.1J for the non-filled 
lower molecular weight HDPE 
compared with 93.6J for the non-filled 
high molecular weight HDPE. The 
impact energy absorbed decreased to 
7.6J for the high molecular weight 
HDPE and to less than 2J for the lower 
molecular weight HDPE when these 
were filled with 40vol% HA. As with 
the studies changing the HA filler 
morphology the tougher material 
showed longer drawn polymer fibrils 
on the fracture surfaces.  
 
MATERIAL MODIFICATIONS 
Failure of such composites is initiated 
by debonding of the filler matrix 
interface (Friedrich and Karsch, 1983; 
Bonfield et al., 1998). Chemically 
coupling the HA and the PE phases to 
increase the mechanical properties was 
investigated by Deb and colleagues 
(Deb et al., 1996; Wang et al., 2000; 
Wang & Bonfield, 2001) who silanated 
the HA phase and acrylic acid coupled 
the PE. Silane coupling without acrylic 
acid grafting reduced the Young’s 
modulus and did not affect the strength 
however, the Young’s modulus and 
tensile strength were increased when 
both silane coupling and grafting were 
combined. However, the most 
substantial difference was the increase 
in the strain to failure at both 20 and 
40vol% filler by silane coupling with 
or without acrylic acid grafting (Table 
2). 
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Table 2 Mechanical properties of HA/PE composites at 20 and 40vol% HA showing 
the effect of silane coupling and acrylic acid grafting showing significant differences 
at * p<0.05 and ** p<0.01 when compared to the non-coupled, non-grafted material 
of the same volume fraction (from Deb et al., 1969). 
Filler 
volume 
content 
Silane 
coupling 
Acrylic 
acid 
grafting 
Tensile 
Strength 
/MPa 
Young’s 
Modulus 
/GPa 
Strain to 
Fracture 
/% 
20 No No 17.77 ± 0.09 1.60 ± 0.02    34.0 ± 9.5 
20 Yes No 17.01 ± 0.19** 1.54 ± 0.02* >100 
20 Yes Yes 19.97 ± 0.07** 1.81 ± 0.05**    39.7 ± 1.5 
30 No No 22.67 ± 0.17 4.29 ± 0.17       2.6 ± 0.4 
30 Yes No 22.08 ± 0.05 3.66 ± 0.20**       7.8 ± 0.6** 
30 Yes Yes 23.16 ± 0.40* 3.87 ± 0.21*       6.8 ± 0.6** 
 
 
 
A different approach to increase the 
mechanical properties was used by 
Ladizesky et al. (1997), McGregor et 
al. (2000), (Wang et al., 2000) and 
Bonner et al. (2002). They 
hydrostatically extruded HAPEX™ to 
orientate the polymer chains and thus 
produce an anisotropic material. 
Extrusion ratios of up to 11:1 were 
used to increase the stiffness and 
flexural strength. While the stiffness 
continued to increase with increases in 
the extrusion ratio the flexural strength 
and ductility peaked at an extrusion 
ratio of 8:1 (Figure 4). All the 
materials were ductile and at the 
highest extrusion ratios the failure was 
due to fibrillation parallel with the 
extrusion direction, rather than actual 
fracture of the material.  
 
Figure 4 Effect of extrusion ratio on the flexural strength (♦), flexural modulus () 
and strain to failure () of hydrostatically extruded 40vol % HA/PE (from Bonner et 
al., 2000)  
 
More recently selective laser sintering 
(SLS) was used to manufacture porous 
scaffolds of HA/PE and HA/polyamide 
(HA/PA) composites (Savalini et al., 
2006 & 2007; Hao et al., 2006a, 
2006b, 2007, 2009; Zhang et al., 
2008). Twin screw extrusion was used 
to process the composites which were 
then ground down into particles of the 
order of 40 to 300µm across. These 
composite particles were then sieved 
into  two groups, those with particle 
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size greater or less than 165µm and 
these were selectively laser sintered. A 
purpose built SLS system was 
manufactured to allow infrared heating 
of the powder to just below the 
polymer melt temperature and then 
low laser power (<10W) could be used 
to perform the sintering. By optimising 
the particle size and laser power 
scaffolds of 20vol% HA/PE and 
30vol% HA/PA could be sintered 
successfully. Infiltration of the samples 
with resin and subsequent sectioning 
and polishing for microscopy showed 
that the material was all open celled 
which is essential for tissue ingrowth 
(Figure 5). Optimisation studies 
showed that 20vol%HA in PE and 
30vol% HA in PA produced the 
greatest consolidation. Dynamic 
mechanical analysis was used to 
measure the mechanical properties as 
this allowed much smaller test samples 
to be used (Zhang et al., 2008). The 
stiffness was lower than of the fully 
dense material, but still had moduli of 
0.7GPa at 37˚C compared to 2GPa for 
the fully dense compression moulded 
HA/PE composite. 
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Figure 5 Optical micrographs of selectively laser sinterered 20vol% HA in PE 
showing the infiltration of the resin and thus that it is and open celled material with 
each particle composed of HA/PE composite. Scale bars are 50µm, 50µm and 10µm 
respectively (From Zhang et al., 2008). 
 
 
MECHANICAL TESTING 
The initial mechanical testing 
concentrated on quasi-static testing to 
optimise the production methods using 
compression moulded samples 
although some both injection moulded 
samples were tested. Implants are 
subjected to both creep and fatigue 
loading in vivo. Suwanprateeb et al. 
(1995) investigated the creep 
behaviour at 37˚C in saline and started 
with isochronous testing, where a 
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small stress is applied for 100s and 
then measuring the strain at the end of 
the loading time, followed by 
unloading for 400s and then applying a 
higher strain for 100s and continuing 
with gradually increasing stress levels 
to produce isochorous stress-strain 
curves (Figure 6). These isochronous 
tests allowed basic comparison of the 
creep behaviour of the difference 
volume fracture fillers and the 
optimisation of load levels for 
conventional long term creep testing. 
They found that increasing the filler 
content from 0 to 20vol% or 20 to 
40vol% halved the creep strain for a 
given applied load, however these 
increases in filler content also 
decreased the time to creep rupture. In 
subsequent studies (Suwanprateeb et 
al., 1997, 1998) they showed that pre-
soaking the composite in saline at 37˚C 
increased the strain deformation due to 
the plasticising effect of the absorbed 
liquid, but that gamma irradiation 
decreased the creep due to the cross-
linking of the polymer and finally that 
thermal annealing also decreased the 
creep and increased gthe time to creep 
rupture (Figure 7).  
 
a) b)  
Figure 6 Isochronous creep testing of HAPEX showing a) the loading regime and b) 
the results obtained for high density polyethylene (HDPE) and reinforced with 20 (20 
HA/PE) and 40vol% HA (40 HA/PE) (from Suwanprateeb et al., 1995). 
a)  b)  
Figure 7 a) Influence of immersion upon the creep behaviour of 2.5Mrad γ-irradiated 
40 HA/PE at 6 MPa applied stress at 37˚C in Ringer’s solution: ---- non-immersed, - . 
- 1 day, ____ 7 days, ……. 90 days,  __ __150 days (from Suwanprateeb et al., 1997) and 
b) effect of thermal annealing on the creep behaviour (from Suwanprateeb et al., 
1998). 
 
Ton That et al. (2000 a & b) studied 
the fatigue behaviour of HAPEX™ 
under both uniaxial tension-
compression and when combined with 
fully reversed torsional loading. As to 
be expected for a filled polymer the 
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tensile phase of the loading caused 
more damage to the material than the 
compressive phase as the interface 
between the polymer and the HA 
opened up. This behaviour lead to non-
symmetrical stress strain loops with 
dynamic creep and increased energy 
absorbed per load cycle. However, 
fully reversed torsional loading 
produced symmetrical loops which 
reduced in secant modulus and 
increased in energy absorbed as the 
material failed (Figure 8). Failure was 
seen first as a reduction in the secant 
modulus followed by an increase in the 
energy absorbed per load cycle. 
Increasing the phase angle between the 
axial and torsional loading increased 
the fatigue life and as with the 
quasistatic and creep testing, failure 
was by debonding of the HA from PE 
and drawing of polyethylene fibrils 
between the filler particles. Joseph & 
Tanner (2005) performed uniaxial 
tensile only fatigue tests, in saline at 
37˚C, with the maximum stress being 
75% of the ultimate tensile strength, on 
40vol% HA/PE manufactured using 
both spray dried and sintered HA. 
They found that the energy absorbed 
per load cycle was higher and the 
secant modulus was lower with the 
sintered filler particles. These 
differences lead to earlier initiation of 
failure with the sintered filler particle 
composite.  
 
a)  
b)  
Figure 8 Stress strain loops for fully reversed a) tension compression at ±50% of 
ultimate tensile strength and b) torsion at ±50% of ultimate shear strength (from Ton 
That et al., 2000a) 
 
Nazhat et al. (2000) used dynamic 
mechanical analysis (DMA) at 1HZ 
and using a temperature scan between 
20 and 100˚C, of different volume 
fraction HA/PE using the same spray 
dried HAs with different particle sizes 
and the same PE as used by Wang et 
al. (1998b). Similar to other studies, 
they found that increasing the filler 
content increased the stiffness and that 
the smaller particle size lead to higher 
modulus for a given volume fraction. 
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The use of DMA allowed the damping 
to be measured as tanδ, the ratio of the 
loss modulus (E”) to the storage 
modulus (E’) and this was found to 
increase with increasing temperature, 
but to be reduced by higher filler 
content with minimal differences 
between the two types of filler 
particles.   
Eniwumide et al. (2004) used compact 
tension testing to measure the fracture 
toughness of composites manufactured 
with two different molecular weight 
PE and both sintered and sprayed dried 
HA. They showed that testing the 
material at 37˚C rather than room 
temperature increased the fracture 
toughness from 1.30±0.04 MN m-3/2 to 
1.34±0.07 MN m-3/2 for 40vol% 
HA/PE manufactured with 240,000 
molecular weight PE. When the 
molecular weight was reduced to 
50,000 the fracture toughness 
decreased to 0.5 MN m-3/2 while 
decreasing the specific surface area of 
the filler particles increased the 
fracture toughness.  
To elucidate the failure mechanisms 
Guild and Bonfield (1993 & 1998) 
used microscale FEA modelling of 
spherical filler particles in a polymeric 
matrix. The tensile modulus estimated 
from the FEA analysis is slightly lower 
than that measured experimentally at 
intermediate filler contents. They 
showed that the highest stresses 
occurred at the poles of the filler 
particles thus the failure started by 
debonding of the filler from the 
polymer and thus that the filler 
particles are seen between drawn 
fibrils as has been seen from 
mechanical testing. They also showed 
the increase in stress concentration at 
about 40vol% filler in agreement with 
the experimental results presented in 
Bonfield (1988) (Figure 9). 
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a) 
 b)  
c)  
Figure 9 a) Comparison of the Young’s modulus of HA in PE measured 
experimentally (■) and predicted using FEA modelling with the PE bulk modulus at 
5GPa (◊) and 10GPa (), b) contours of stress concentration of the von Mises stress 
in the polyethylene matrix viewed from the centre of the HA sphere, with the sphere 
removed and c) effect of volume fraction of HA spheres on the stress concentration 
factor (from Guild & Bonfield, 1998). 
 
 
IN VITRO TESTING OF 
BIOACTIVITY 
When HAPEX™ was initially 
developed cell culture on biomaterials 
was insufficiently developed to be 
used to assess the biological response 
to materials. Thus the initial biological 
assessment was performed in vivo 
(Doyle et al., 1990). As cell culture 
studies on biomaterials developed in 
vitro studies of HAPEX™ were 
performed. Di Silvio and colleagues 
(Huang et al. 1997 b & c; Di Silvio et 
al. 1998; 2002 a & b; Dalby et al., 
1999, 2000, 2002) cultured osteoblasts 
obtained at elective surgery from 
human femoral heads on various 
HA/PE composites and showed that 
the material was biocompatible. Huang 
et al. (1997b) and Di Silvio et al. 
(1998) also showed that the osteoblasts 
proliferated and matured faster on 
HAPEX™than on plain PE although 
the response was slower on both the 
composites than on Thermanox 
(polyethylene terephthalate) coverslips 
used as a control (Figure 10a). The 
most interesting finding was that the 
osteoblasts cell processes attached 
down onto the HA particles in obvious 
preference to the surrounding PE 
(Figure 10b).  
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a) b)  
Figure 10 a) Alkaline phosphatase activity on samples of HAPEX™ and PE with 
Thermanox (TMX) as a control surface and b) osteoblasts attaching down on to the 
HA particles in HAPEX™ (from Huang et al., 1997b). 
 
In a later study (Di Silvio et al., 2002a) 
20 and 40vol% HA/PE were compared 
with Thermanox controls. Cell 
proliferation was measured using 
tritiated thymidine incorporation and 
cell differentiation using alkaline 
phosphatase activity. The cells 
proliferated faster on the 40vol% 
HA/PE than on the 20vol% HA/PE and 
then differentiated more, the difference 
peaking at day 7 of culture. Scanning 
electron microscopy showed the 
osteoblasts attaching down on to the 
HA particles and showed cells in the 
process of division. Confocal laser 
microscopy showed actin stress fibres 
in the cells and with vinculin staining 
adhesion plaques could be seen, 
although the number of adhesion 
plaques and actin fibres were higer and 
more organised on the 40vol% HA/PE 
than the 20vol% HA/PE. Transmission 
electron microscopy of the cell culture 
showed more collagen was formed 
between the cells with the higher HA 
content.  
Dalby et al. (2000) showed the 
importance of surface features by 
culturing osteoblasts on machined 
rather than polished surfaces of 
HAPEX™. The osteoblasts aligned 
themselves with the grooves on the 
surface. Rea et al. (2004c) also 
investigated the effect of surface 
texture and produced a series of 
different grooves pillars and pits on the 
surface of HAPEX™. They found that 
compared to a polished surface there 
was not much difference in the cell 
number on the textured surfaces with 
the possible exception of 0.3mm wide 
grooves (Figure 11). However, cell 
differentiation, as measured by 
alkaline phosphatase activity was 
increased on the textured surfaces.  
 
  15 
a) b)  
Figure 11 Effect of surface texture on osteoblast attachment to a) grooved with 
grooves 50µm deep and 50µm wide and b) pitted with pits 50µm deep and 50µm 
wide and polished areas of HAPEX™ all marker bars =100µm (from Rea et al., 
2004c) 
 
The importance of the HA morphology 
was shown by Zhang et al. (2007) who 
cultured osteoblasts on polished 
sections of 30vol% HA/PE 
manufactured using the sintered and 
spray dried HA particles investigated 
in Zhang & Tanner (2008). Three 
control materials were used, 100%PE 
and 100% HA in addition to 
Thermanox. When the composite 
surface was polished the spray dried 
particles were seen to be slightly 
porous and thus textured while the 
sintered particles were solid and thus 
smooth when polished (Figure 12 a & 
b). The osteoblasts were from both 
human femoral heads removed at hip 
replacement and from human calveria, 
again taken at elective surgery. The 
human calveria origin cells reacted 
slightly more slowly than those from 
the femoral heads although with a 
similar trend. Both origin cells 
attached with more, but finer, cell 
processes on to the spray dried HA 
containing composite than the sintered 
HA composite with higher cell 
proliferation followed by higher cell 
differentiation (Figure 12c). However 
these responses were higher and faster 
on the composite than either the plain 
polyethylene or the solid HA.  
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a) b)  
c)  
Figure 12 The interaction of femoral head origin osteoblasts with 30vol% HA/PE 
manufactured using a) spray dried HA and b) sintered HA particles and c) the alkaline 
phosphatase activity of osteoblasts from femoral heads (HOBf) and calvaris (HOBc) 
cultured on Thermanox controls (TMX), non-filled PE (PE), 30 vol% spray dried HA 
in PE (30ol%HA1-PE), 30 vol% sintered HA in PE (30vol%HA2-PE) and HA (HA) 
(from Zhang et al., 2007). 
 
 
The cellular response to selectively 
laser sintered HA/PE and HA in 
polyamide (HA/PA) composites were 
investigated by Zhang et al. (2009). 
They used 20vol% HA and 30vol% 
HA in PE, as processing constraints 
had shown these to be the highest HA 
content possible in these two matrix 
materials (Savalini et al., 2006 & 
2007; Hao et al., 2006a, 2006b, 2007, 
2009; Zhang et al., 2008). In this study 
two controls were used, Thermanox 
which should lead to a beneficial 
cellular response and tin doped 
polyvinylchloride (SnPVC) a known 
toxic material. The cell proliferation 
and differentiation were higher on the 
30vol%HA/PA than the 
20vol%HA/PE, but the production of 
osteocalcin, a marker for bone 
mineralization, was higher on both 
composites than on the Thermanox 
(Figure 13). Cell culture was 
progressed through to 28 days and, 
without the addition of dexamethasone 
or any other additional factors to drive 
bone mineralization, on both the 
composites mineralised nodules were 
seen indicating the strong drive for the 
osteoblasts to progress through to bone 
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formation.  
 
)  b)  c) 
 
Figure 13 The interaction of human osteoblasts on selectively laser sintered a) 20vol% 
HA/PA and b) 30 vol% HA/PA and c) osteocalcin levels on Themanox control 
(TMX), electively laser sintered 20vol% HA/PA (SLSHAPE) and 30 vol% 
HA/PA(SLSHAPA) with differences by Student’s t-test, * = p < 0.05, *** = p <0.001 
(From Zhang et al., 2009).  
 
 
IN VIVO TESTING OF 
BIOACTIVITY 
The in vivo biocompatibility and 
bioactivity testing was started before 
the in vitro as the development of this 
material pre-dated the use of in vitro 
cell culture studies for biocompatibility 
testing. In the first of these studies 
Bonfield et al. (1986) implanted rivet 
shaped implants of HAPEX™ with 
non-filled PE as a control into the 
femoral shaft of rabbits, passing 
through both cortical and cancellous 
bone. While the PE was surrounded 
with a fibrous layer direct bone contact 
onto the HAPEX™ was seen. In later 
studies high resolution TEM was used 
to investigate the crystallographic 
detail of this interface and showed that 
the mineral phase in the newly formed 
bone was aligned with that in the HA 
in the composite indicating that the 
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newly formed bone appeared to be 
using the HA on the composite surface 
to nucleate mineralisation (Doyle et 
al., 1990).  
Tanner et al. (1990) performed push-
out testing to measure then strength of 
the interface produced bone and 
between HAPEX™, apatite-
wollastonite (A-W) glass ceramic 
provided by Professor Kokubo or non-
filled PE. Even after 3 months 
implantation the non-filled PE-bone 
interface failed with a shear strength of 
than 0.6MPa, while the A-W glass 
ceramic-bone interface reached 20MPa 
and the HAPEX™-bone interfacial 
strength gradually increased up to 
10MPa at 3 months.  
Revell et al. (1997) implanted rods 
into the distal femora of rabbits, each 
rod had a slot cut into in 2mm deep 
and 2mm across. Two materials were 
used, HAPEX™ and titanium where 
the inside of the slot was plasma 
sprayed with HA (Ti+HA) to model 
plasma sprayed titanium used for the 
stems of non-cemented joint 
replacements. After 5 weeks the new 
bone formation was down to the 
bottom of the HAPEX™ slot and filled 
80% of the available space unlike the 
Ti+HA where the new bone filled only 
25% of the available space (Figure 14).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 Section through the base of the slot machined into a HAPEX™ cylinder and 
implanted in a rabbit knee for 5 weeks (from Revell et al., 1977). 
 
CLINICAL APPLICATIONS 
HAPEX™ was the first of the bioactive 
composites implanted into patients and 
was used by Downes et al. (Downes et 
al. 1991; Tanner et al., 1994) in orbital 
floor applications. The two designs of 
implants either filled the space left 
after an eye was removed to allow the 
artificial eye to fit better or restored 
eye alignment in patients with orbital 
floor fractures. These were low load 
bearing applications, but showed that 
the material encouraged the supporting 
bone to bond to the implant material. 
Previous implants were manufactured 
of silicone and manual palpation had 
shown them lie loose in a fibrous 
capsule and some extruded. None of 
the HAPEX™ implants moved on 
palpation or were extruded. CT images 
(Figure 15) showed no gaps between 
the implant and the supporting bone.  
 
HAPEX™
™ 
New 
bone 
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Figure 15 An HAPEX™ implant in the orbital floor of a patient who has lost an eye. 
The HAPEX™ implant is shown on the right of the image with the same radiographic 
density as the bone to which it is bonded while the spherical black object is a glass 
ball implanted in an earlier attempt to increase the volume of material in the orbital 
socket (from Downes et al., 1991) 
 
This initial study had only 18 patients, 
but allowed the material to be used by 
Smith & Nephew ENT to manufacture 
the shaft of a range of middle ear 
implants including the Goldenberg 
(Goldenberg, 1994) and Dornhoffer 
(Dornhoffer, 1998) implants. These 
implants consist of a monolithic HA 
head on a shaft and are designed to 
replace the mechanical function of 
sound transmission through the three 
bones of the middle ear. The HA head 
is placed against the tympanic 
membrane (ear drum) and the surgeon 
cuts the shaft to fit the individual 
patient. The range of implants allows 
for patients where all three bones of 
the middle ear have been lost or 
damaged or where only two bones 
were affected and the stapes is still 
present. Originally, the shafts were 
manufactured of PE and the surgeon 
trimmed them to shape with a scapel 
blade, when the PE shafts were 
replaced with HAPEX™ shafts the 
ability of the surgeon to trim the 
implant to shape was retained and 
indeed improved (Figure 16). One 
study by Meijer et al. (2002) has 
reported the clinical application of 
these implants. They used Scanning 
Electron Microscopy to review the 
response to 11 HAPEX™ implants 
which had been removed due to re-
occurrence of the original clinical 
problem, rather than for device failure. 
In most of the cases the implants were 
covered with fibrous tissue and in half 
of these there was a thin epithelial 
outer layer. The response to 
implantation was considered to be 
good even upt o 30 months 
implantation. Also in no cases were 
macrophages or other signs of 
inflammation seen, unlike similar 
retrieved implants manufactured of 
Proplast® or Plastipore® where 
macrophage activity was obvious and 
some inflammation was seen. 
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Figure 16 Middle ear implant in situ showing the notch cut in the HAPEX shaft to 
allow the implant to sit over the arch of the stapes (top) and the HA head resting on 
the tympanic membrane (bottom).  
 
OTHER COMPOSITES 
This work with hydroxyapatite 
reinforced polyethylene has lead to a 
range of other potentially bioactive 
composites to be investigated., both by 
Bonfield and his colleagues and by 
other groups. These composites can be 
degradable or non-degradable 
depending on the matrix polymer. For 
non-degradable materials PE remains 
the most popular matrix material, 
while a range of degradable polymers 
have been used as matrix materials in 
composites, including polylactic acid 
and polyhydroxybutyrate.  
Harper (1998) reinforced PMMA bone 
cement with 17wt% (6vol%) HA in an 
attempt to confer bioactivity without 
reducing the mechanical properties. 
Dalby et al. (1999 & 2001) 
investigated the cellular response to 
this composite. The addition of the HA 
increased the cellular response to the 
PMMA with again the osteoblast 
processes attaching down onto the HA 
particles and higher actin organisation 
in the cells grown on the filled PMMA 
than the non-filled (Figure 17). Bonner 
et al. (2001) reported the manufacture 
and hydrostatic extrusion of 
polypropylene reinforced with 40vol% 
HA (HA/PP). Hydrostatic extrusion 
increased the modulus from 7.5 to 
9.3GPa and the flexural strength from 
25 to over 80MPa. Neither of these 
materials have progressed beyond the 
initial testing.  
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Figure 17 Actin cytoskeleton (green)/vinculin (red) interaction surrounding the cell 
nucleus (blue) on a) PMMA and b) PMMA reinforced with 6vol% HA (from Dalby et 
al., 2001). 
 
 
In the 1980s, polyhydroxybutyrate 
(PHB) and its co-polymer 
polyhydroxyvalerate (PHV) were 
being developed as biodegradable 
polymers with similar mechanical 
properties as polypropylene. Doyle et 
al. (1991) manufactured HA reinforced 
PHB and characterised the mechanical 
properties and performed in vivo 
analysis of the material, including push 
out testing similar to that performed by 
Tanner et al. (1990). The non-filled 
PHB had a Young’s modulus of 4GPa 
which was increased to 11GPa with the 
addition of 40vol% HA however the 
tensile strength dropped from 37MPa 
to 22MPa. The biological response to 
implantation of 40vol%HA/PHB was 
bone ongrowth (Figure 18), but in push 
out-testing failure occurred though the 
material rather than at the implant-
bone interface as occurred with HA/PE 
composites. Luklinska and Bonfield 
(1997) using high resolution TEM 
showed that the bone had bonded 
across the interface. Knowles and 
Hastings (1993) manufactured 
composites by dry blending phosphate 
based glasses 20 to 40wt% into PHB 
with 7vol%PHV and then injection 
moulded samples. The presence of the 
glass accelerated the degradation. 
However, these studies stopped the 
cessation of production of medical 
grade PHB for commercial reasons. 
However more recently PHB has again 
been used in bioactive composites such 
as PHB reinforced with 5 and 15wt% 
HA short fibres produced by Coskun et 
al. (2005) and PHB12%PHV 
reinforced with up to 14vol% nanoHA 
produced by Chen et al. (2007). As a 
matrix material PHB has the 
advantages of higher modulus than 
most other degradable polymers, 
furthermore by including PHV the 
ductility can be increased although 
with reductions in the stiffness and 
strength. 
 
 
  22 
 
Figure 18 Interface developed between cortical bone and 40vol% HA/PHB after 1 
month marjer bar = 100µm (from Luklinska and Bonfield, 1997). 
 
In contrast to these composites with 
different polymers reinforced with HA, 
Huang et al. (1997 a & c; 1998) and 
Wang et al. (1998a) reinforced 
polyethylene with Bioglass®. Again 
increases in the modulus were seen 
with the addition of the Bioglass®, 
however, the sharp corners of the 
Bioglass® lead to stress concentrations 
and thus significant reductions in the 
strength (Figure 19). However, the 
response to soaking in simulated body 
fluid was excellent with dissolution of 
the Bioglass® acting to initiate the 
development of a hydrated carbonate 
layer (HCA) which started from the 
Bioglass® particles and then 
progressed across the composite 
surface (Figure 20). The material was 
seen to be biocompatible with 
increased cell viability when cultured 
in cell culture medium that had been 
exposed to the composite for 24 hours. 
This increase in cell viability was 
presumably due to the ions released 
during the dissolution of the Bioglass® 
in the cell culture medium.  
 
Figure 19 Comparison of the reinforcing effects of hydroxyapatite (HA) Bioglass® 
and A-W glass ceramic in polyethylene on the Young’s modulus and tensile strength 
at a range of volume fractions. 
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a) b)  
Figure 20 Polished sections of 40vol% Bioglass® reinforced PE a) polished section 
and b) after 7 days in simulated body fluid (from Huang et al 1997a) 
 
Judhasz et al. (2003 & 2004) 
reinforced PE with A-W glass-ceramic 
and again found that the addition of the 
glass-ceramic increased the stiffness of 
the composite, but due to the shape of 
the A-W glass ceramic particles stress 
concentrations lead to low strength 
materials. However the bioactivity as 
measured be time to produce a surface 
layer after soaking in SBF was 
excellent. With even as little as 
10vol% A-W glass-ceramic 100% of 
surface of samples was covered in 3 
days and with 50vol% total coverage 
took less than 6 hours. Rea et al. (2004 
a, b & c) compared the response of 
osteoblasts like cells on HAPEX™ and 
A-W glass ceramic-PE composites and 
showed that as with HAPEX™ when 
the cells were cultured on A-W glass 
ceramic-PE they preferentially 
attached down on the filler particles 
via filopodia. The response increased 
with increasing A-W glass ceramic 
content but for all surface textures, be 
they grooves, pits or pillars the 
response, in terms of cell proliferation 
and differentiation, was higher on 
HAPEX™ than on A-W glass ceramic-
PE (Figure 21). 
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a)  
b)  
Figure 21 a) an osteoblast growing A-W glass ceramic in PE composite showing the 
cell attaching preferentially onto the A-W glass ceramic particles and b) the increases 
in cell number with time for 30 and 50vol% A-W glass ceramic in PE with mean 
particle sizes of 4.5µm and 7.7µm (from Rea et al., 2004b). 
 
 
The idea of reinforcing a polymer with 
a bioactive filler was taken further by 
Törmälä et al. (1997) and Bleach et al. 
(2001, 2002) who reinforced polylactic 
acid (PLA) with HA or tricalcium 
phosphate (TCP) particles and then 
used this composite to act as the matrix 
around drawn PLA fibres thus creating 
a three phase fibre reinforced 
composite. The stiffness and strength 
were at the lower bounds of those for 
cortical bone at over 7GPa and 70MPa 
respectively. An interesting effect of 
adding HA or TCP was to chemically 
buffer the degradation of the PLA so 
that the start of loss of strength was 
delayed from 8 weeks to 12 weeks. 
DMA performed by Nazhat et al. 
(2001) at 1Hz test frequency and 
scanning from -50 to +100˚C showed 
the glass transition temperatures for 
both the PLAs used in the manufacture 
of the composite. The drawn fibres 
increased the storage modulus from 3.5 
to over 7GPa and that the loss modulus 
was relatively unaffected by 
temperature upto the glass transition 
temperature.  
 
Other composites containing polymer 
fibres have been developed. For 
example Waris et al. (1994)  
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manufactured plates of PLA reinforced 
PLA and used these in the repair of 
skull defects in growing children as the 
degradation of the plates allowed skull 
growth continue once the plate had 
disappeared.  More recently some of 
the studies using fused deposition and 
electrostatic spraying have used 
composites of  
 
CONCLUSIONS 
The idea of adding HA to polymers 
has lead from the bioinert monolithic 
materials used in the 1970s and 1980s 
through to the bioactive biodegradable 
composites used now as modulus 
matched materials and more recently 
as the scaffolds for tissue engineering. 
The work has lead to the application of 
conventional composite manufacturing 
techniques in the field of biomaterials, 
with materials that have similar 
mechanical properties to bone. The 
addition of the bioactive phases has 
lead to materials that have been shown 
to be bioactive in both in vitro studies 
using soaking in simulated body fluid 
and in vitro cell culture where the 
interaction of the cells will the filler 
phases has indicated the manner of the 
biological and cellular response in 
vivo. Finally the materials have been 
used clinically leading to 
improvements in the quality of life of 
patients worldwide.  
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